Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - Canaccord Genuity downgraded Cineplex Inc . (TSX:CGX) stock rating from Buy to Hold while maintaining a price target of C$11.00.
The Canadian cinema operator reported its Q2/25 results with revenue aligning with analyst expectations, though adjusted EBITDAaL came in slightly below forecasts due to underperformance in the Rec Room segment, weaker Cinema Media results, and higher film costs.
Cineplex posted a 32.7% year-over-year increase in Q2 attendance, benefiting from a strong film slate and comparisons against a soft prior-year period that was impacted by the writers’ strike.
Canaccord Genuity expects Cineplex’s box office performance to decline in Q3 before recovering in Q4, identifying potential future catalysts including improved returns from Cinema Media and Rec Room segments, along with a possible dividend announcement likely in 2026.
The downgrade comes as Cineplex shares approach Canaccord’s target price, with the research firm citing "somewhat lowered visibility around the degree of FCF upside" despite projecting 92% free cash flow growth in fiscal 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.